Pain Therapeutics (PTIE)

Add to Watchlists
Create an Alert
5.70 +0.24  +4.40% NASDAQ Apr 22, 8:00PM BATS Real time Currency in USD
View Full Chart
PTIE Price Chart
View All Events

PTIE Events

Date Type Description
Feb 04 Misc Pain Therapeutics, Inc. 4Q2013 Earning Conference Call
Feb 04 Earnings Pain Therapeutics, Inc. 4Q2013 Earning Result. Estimate: -0.01.
Feb 04 Misc Pain Therapeutics Reports 2013 Financial Results and Provides Guidance for 2014
Oct 31 Earnings Pain Therapeutics Reports Q3 2013 Financial Results. Estimate: -0.01.
Aug 01 Earnings Pain Therapeutics Reports Q2 2013 Financial Results. Estimate: -0.02.
May 16 Misc AGM Event for Pain Therapeutics Inc
Apr 24 Earnings Pain Therapeutics Reports Q1 2013 Financial Results. Estimate: -0.01.
View All Performance Charts

PTIE Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Pain Therapeutics is up 83.28% over the last year vs S&P 500 Total Return up 23.42%, Durect up 3.08%, and Pfizer up 3.53%.

Get Quote for

Portfolio Strategies Featuring PTIE

Did Pain Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PTIE Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: Texas
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: December 31, 2013
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Pain Therapeutics, Inc., is a biopharmaceutical company that develops novel drugs. It has four drug candidates in clinical programs, including Remoxy, Oxytrex, PTI-202 and a novel radio-labeled monoclonal antibody to treat metastatic melanoma.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PTIE 5.70 +0.24 +4.40% 259.41M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.